Linezolid and Repaglinide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Linezolid (linezolid) and Repaglinide (repaglinide). Common drug interactions include subcutaneous abscess among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Linezolid and Repaglinide. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Linezolid?

Linezolid has active ingredients of linezolid. It is often used in infection. eHealthMe is studying from 21,891 Linezolid users. Check the latest studies of Linezolid.

What is Repaglinide?

Repaglinide has active ingredients of repaglinide. It is often used in diabetes. eHealthMe is studying from 8,226 Repaglinide users. Check the latest studies of Repaglinide.

On Aug, 01, 2026

31 people who take Linezolid and Repaglinide together, and have interactions are studied.

Linezolid and Repaglinide drug interactions.

What are the common drug interactions of Linezolid and Repaglinide, by gender? *:

female:

Subcutaneous abscess
Abscess (pus)
Ankylosing spondylitis (type of arthritis affecting the spine)
Cellulitis (infection under the skin)
Device related infection
Neutropenia (an abnormally low number of neutrophils)
Sepsis (a severe blood infection that can lead to organ failure and death)
Septic shock (shock due to blood infection)
Acute respiratory failure
Anaemia (lack of blood)

male:

Anaemia (lack of blood)
Thrombocytopenia (decrease of platelets in blood)
Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Febrile neutropenia (fever with reduced white blood cells)
General physical health deterioration (weak health status)
Bacteraemia (presence of bacteria in the blood)
Bicytopenia (two parameters from the full blood count are low, the term bicytopenia can be used)
Drug eruption (adverse drug reaction of the skin)
Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)

What are the common drug interactions of Linezolid and Repaglinide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Scrotal abscess (pus in scrotum)
Sepsis (a severe blood infection that can lead to organ failure and death)

50-59:

Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)

60+:

Anaemia (lack of blood)
Thrombocytopenia (decrease of platelets in blood)
Subcutaneous abscess
Abscess (pus)
Ankylosing spondylitis (type of arthritis affecting the spine)
Cellulitis (infection under the skin)
Device related infection
Neutropenia (an abnormally low number of neutrophils)
Sepsis (a severe blood infection that can lead to organ failure and death)
Septic shock (shock due to blood infection)

What are the existing conditions these people have? *

Pneumonia: 9 people, 29.03%
High Blood Pressure: 9 people, 29.03%
Osteitis (a general term for inflammation of bone): 8 people, 25.81%
Insulin-Requiring Type 2 Diabetes Mellitus: 7 people, 22.58%
Barrett's Oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach): 7 people, 22.58%
Arteriosclerosis Coronary Artery (thickening and hardening of arteries- coronary artery): 7 people, 22.58%
Type 2 Diabetes: 4 people, 12.90%
Weight Decreased: 3 people, 9.68%
Hypotension (abnormally low blood pressure): 3 people, 9.68%
Tumor: 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Linezolid and Repaglinide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously